SeaStar Medical Holding Corp

ICU

SeaStar Medical Holding Corp

ICU

Insider Sentiment (TTM):

Last Purchase:2025-12-19Last Sale:-Shares Purchased (TTM):28,700Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:131,394Shares Outstanding:3,918,339Institutional Ownership Pct.:3.35%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	-	0	0
Cash	7	9	12	14	6	5	2	2	1	5	0	0
Assets
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	-	-	0	-
Assets Current
Assets Current	8	11	14	15	8	7	4	4	2	7	2	2
Inventory Net	0	0	0	0	0	0	0	-	-	-	-	-
Prepaid Expense Current	1	1	1	1	1	1	2	1	1	2	2	2
Other Assets	-	-	-	-	1	1	1	1	1	1	1	0
Other Assets Noncurrent	0	0	1	1	-	-	1	-	-	-	-	-
Assets	9	11	14	16	8	14	5	5	3	8	4	2
Accounts Payable Current	1	1	1	2	3	3	3	4	4	4	4	5
Liabilities And Stockhold…
Accrued Liabilities Current	3	3	2	2	2	3	3	2	2	2	2	1
Liabilities Current
Liabilities Current	4	4	4	4	5	7	7	7	10	10	13	12
Notes Payable Current	0	0	1	0	0	0	1	0	3	0	1	0
Derivative Liabilities Current	0	0	0	0	-	-	0	-	-	-	-	-
Contract With Customer Liability Current	-	-	-	-	-	-	0	1	0	-	0	-
Liabilities	4	4	4	4	5	7	7	7	10	12	17	18
Convertible Debt Current	-	-	-	-	-	-	0	0	0	1	4	4
Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Notes Payable	-	-	0	-	-	-	0	0	0	3	4	6
Stockholders Equity
Stockholders Equity	4	7	10	11	3	1	-2	-0	-7	-4	-14	-16
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	0	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	163	163	162	160	149	144	137	133	124	123	101	100
Convertible Debt Noncurrent	-	-	-	-	-	-	0	0	0	0	0	-
Retained Earnings Accumulated Deficit	-159	-155	-152	-149	-145	-143	-140	-135	-131	-127	-115	-116
Liabilities And Stockholders Equity	9	11	14	16	8	8	5	5	3	8	4	2
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	-	0	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	425	425	450	450	450	450	500	500	500	500	500	500
Common Stock Shares Issued	4	4	4	34	2	1	1	0	0	0	0	0
Shares Outstanding	4	4	4	34	2	1	1	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-36.09%	6.96%	-30.87%	-	-	-	-	-	-	-	-	-
2025	3.25%	-54.96%	-46.75%	9.35%	-10.73%	-21.60%	-21.74%	-42.83%	-48.26%	84.21%	73.25%	30.70%
2024	-43.56%	-1.65%	-15.26%	-20.26%	-29.49%	-50.08%	-10.71%	-16.67%	-11.11%	-43.18%	-43.64%	-46.36%
2023	-	-	-	-47.79%	48.07%	130.94%	-7.28%	-13.58%	34.11%	-43.24%	-69.15%	-46.25%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.89	2.73	3.63	3.66	1.52	0.96	0.55	0.54	0.24	0.68	0.18	0.18
Quick Ratio	1.65	2.41	3.26	3.44	1.29	0.77	0.28	0.32	0.12	0.52	0.01	0.01
Working Capital	3.88M	6.82M	9.84M	10.81M	2.61M	-248.00K	-3.08M	-3.02M	-7.52M	-3.11M	-10.74M	-10.18M
Leverage & Debt
Debt to Equity	1.01	0.54	0.36	0.35	1.51	12.45	-3.13	-3,234.89	-1.50	-2.73	-1.25	-1.13
Interest Coverage TTM	-559.64	-459.85	-392.74	-51.00	-27.16	-28.66	-23.79	-23.01	-22.37	-17.17	-13.15	-18.45
Debt Ratio	0.50	0.35	0.26	0.26	0.60	0.50	1.47	1.45	2.99	1.58	4.95	8.08
Efficiency & Turnover
Asset Turnover TTM	0.20	0.11	0.13	0.09	0.13	0.04	0.03	0.02	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	45.28	36.73	51.61	59.87	103.40	93.81	302.81	365.00	-	-	-	-
Receivables Turnover TTM	8.06	9.94	7.07	6.10	3.53	3.89	1.21	1.00	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-12.95	-18.46	-66.33	-73.08	-103.40	-118.59	-302.63	-313.83
Free Cash Flow Per Share TTM	-3.33	-3.50	-6.56	-0.44	-11.21	-17.61	-42.76	-3.87	-38.46	-42.76	-118.65	-138.44
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	92.64%	93.11%	95.71%	95.35%	96.48%	-	-	-	-	-	-	-
Operating Profit Margin TTM	-816.75%	-832.59%	-986.63%	-1,580.48%	-1,932.25%	-4,138.79%	-13,216.30%	-23,547.06%	-	-	-	-
Net Profit Margin TTM	-795.50%	-828.62%	-984.60%	-1,551.08%	-1,915.27%	-3,716.12%	-18,392.59%	-43,923.53%	-	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	123.63%	235.51%	814.07%	1,195.59%	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%
Net Income Growth (1Y)	-7.12%	-25.19%	-51.07%	-54.25%	-55.03%	-50.04%	-5.34%	18.68%	64.53%	74.12%	115.19%	201.27%
EPS Growth (1Y)	-74.23%	-83.55%	-91.16%	-92.92%	-87.48%	-84.44%	-78.08%	-97.67%	-68.85%	-66.20%	-18.46%	8.78%
Valuation Metrics
P/E TTM	-1.10	-1.22	-0.41	-11.01	-0.33	-0.90	-0.29	-5.83	-0.73	-1.55	-0.37	-0.21
P/B TTM	3.49	1.99	0.48	13.12	1.44	25.32	-3.33	-84,844.39	-3.47	-11.00	-0.69	-0.33
P/S TTM	8.75	10.15	4.03	170.76	6.30	33.42	53.80	2,560.30	-	-	-	-
Market Cap	14.99M	14.58M	4.98M	150.44M	4.83M	14.31M	7.26M	174.10M	23.94M	49.26M	9.60M	5.29M
Enterprise Value	8.16M	5.56M	-6.48M	136.68M	-1.48M	9.37M	6.02M	172.02M	25.91M	48.29M	18.50M	15.35M
Calculated Values
Free Cash Flow TTM	-13.59M	-13.71M	-13.60M	-11.54M	-12.70M	-15.17M	-16.01M	-15.80M	-12.13M	-11.48M	-10.29M	-11.10M
Net Debt	-6.83M	-9.02M	-11.46M	-13.76M	-6.30M	-4.93M	-1.25M	-2.08M	1.96M	-962.00K	8.91M	10.05M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-19Purchase

Owner: Baird, Jennifer A

Title: -

Shares: 4,200

Price/Share: $0.24

Value: $1,008.00

Shares Owned: 36,200

Relationship: Director

Ownership: Direct

2025-12-09Purchase

Owner: Messinger, Michael

Title: Chief Financial Officer

Shares: 14,500

Price/Share: $0.35

Value: $5,075.00

Shares Owned: 17,500

Relationship: Officer

Ownership: Direct

2025-08-27Purchase

Owner: Van, Heel Kenneth

Title: -

Shares: 10,000

Price/Share: $0.86

Value: $8,600.00

Shares Owned: 49,400

Relationship: Director

Ownership: Direct

2025-08-22Purchase

Owner: Chung, Kevin

Title: Chief Medical Officer

Shares: 10,000

Price/Share: $0.80

Value: $8,000.00

Shares Owned: 58,184

Relationship: Officer

Ownership: Direct

2025-06-30Purchase

Owner: Baird, Jennifer A

Title: -

Shares: 10,000

Price/Share: $0.42

Value: $4,200.00

Shares Owned: 28,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-19	Baird, Jennifer A	Director	-	Direct	Purchase	4,200	0.24	$1,008.00	36,200	4
2025-12-09	Messinger, Michael	Officer	Chief Financial Officer	Direct	Purchase	14,500	0.35	$5,075.00	17,500	4
2025-08-27	Van, Heel Kenneth	Director	-	Direct	Purchase	10,000	0.86	$8,600.00	49,400	4
2025-08-22	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	10,000	0.80	$8,000.00	58,184	4
2025-06-30	Baird, Jennifer A	Director	-	Direct	Purchase	10,000	0.42	$4,200.00	28,000	4
2025-06-24	Neuman, John	Director	-	Direct	Purchase	40,000	0.36	$14,400.00	80,000	4
2025-05-20	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	4,500	1.25	$5,625.00	18,185	4
2025-05-20	Baird, Jennifer A	Director	-	Direct	Purchase	10,000	1.28	$12,800.00	10,000	4
2024-12-11	Neuman, John	Director	-	Direct	Purchase	10,000	2.04	$20,400.00	40,000	4
2024-11-18	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	4,250	1.99	$8,457.50	13,685	4
2024-09-30	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	1,000	4.26	$4,260.00	9,435	4
2023-11-22	Van, Heel Kenneth	Director	-	Direct	Purchase	100,000	0.40	$40,000.00	116,400	4
2023-05-30	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	12,543	0.48	$6,020.64	68,125	4
2023-05-25	Russell, Richard D.	Director	-	Direct	Purchase	20,000	0.50	$10,000.00	27,978	4
2023-05-18	Chung, Kevin	Officer	Chief Medical Officer	Direct	Purchase	7,500	0.70	$5,250.00	55,582	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.35%

Inst. Shares: 131,394

Shares Outstanding: 3,918,339

2025-12-31

38.47%

Inst. Shares: 797,536

Shares Outstanding: 2,073,087

2025-09-30

4.14%

Inst. Shares: 1,093,735

Shares Outstanding: 26,393,400

2025-06-30

3.87%

Inst. Shares: 438,536

Shares Outstanding: 11,329,517

2025-03-31

104.14%

Inst. Shares: 897,474

Shares Outstanding: 861,794

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	131,394	3,918,339	3.35%
2025-12-31	797,536	2,073,087	38.47%
2025-09-30	1,093,735	26,393,400	4.14%
2025-06-30	438,536	11,329,517	3.87%
2025-03-31	897,474	861,794	104.14%
2024-12-31	165,777	374,356	44.28%
2024-09-30	125,215	4,086,871	3.06%
2024-06-30	146,400	3,154,782	4.64%
2024-03-31	3,774,280	2,684,243	140.61%
2023-12-31	799,490	866,813	92.23%
2023-09-30	240,782	801,939	30.02%
2023-06-30	561,900	597,315	94.07%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

SeaStar Medical Holding Corp (ICU) — SEC Financial Statements & Analysis

SeaStar Medical Holding Corp (ICU) is a surgical & medical instruments & apparatus company, incorporated in CO. SeaStar Medical Holding Corp trades on Nasdaq as: ICU, ICUCW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SeaStar Medical Holding Corp reported a 123.63% year-over-year revenue growth, a Gross Profit Margin of 92.64% (TTM), a Debt-to-Equity ratio of 1.01x, a Price-to-Sales (P/S) ratio of 8.75x (TTM), a Price-to-Book (P/B) ratio of 3.49x (TTM), at a market cap of $14.99M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 123.63%
Gross Profit Margin TTM: 92.64%
Debt To Equity: 1.01x
P/S TTM: 8.75x
P/B TTM: 3.49x
Market Cap: $14.99M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SeaStar Medical Holding Corp in?

SeaStar Medical Holding Corp (ICU) operates in the Surgical & Medical Instruments & Apparatus industry.

What is ICU's market cap?

SeaStar Medical Holding Corp (ICU) has a market capitalization of $14.99M as of 2026-06-30.

What exchange does ICU trade on?

SeaStar Medical Holding Corp (ICU) trades on the Nasdaq.

Where is SeaStar Medical Holding Corp incorporated?

SeaStar Medical Holding Corp is incorporated in CO.